Wow! Great results! Congratulations everyone, well done to all holders especially the long timers who believed in the company from the start. Your patience is rewarded again today. Pleased to see statistical significance in this small sample and consistent scoring between caregiver and clinicians. It really is about as good as you can get, and it also infers the drug is likely to have a positive effect on the other indications which is remarkable.
Enjoy the day
Ann: P2 trial shows significant improvements in Phelan-McDermid, page-137
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.26 |
Change
-0.280(2.23%) |
Mkt cap ! $1.525B | |||
| Open | High | Low | Value | Volume |
| $12.45 | $12.45 | $11.88 | $6.952M | 570.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 231 | $12.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.32 | 1979 | 2 |
View Market Depth
| Last trade - 16.13pm 23/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |